NEW YORK, Sept. 24, 2013 /PRNewswire/ -- ICAP Patent Brokerage announces for sale an expansive medical device portfolio from Wilk Patent Development Corporation et. al.
"This is a strategic portfolio describing an impressive array of portable, inexpensive, and minimally invasive inventions, and, therefore, is highly relevant to companies producing medical devices for diagnostics, surgery and/or treatment," says Dean Becker, CEO of ICAP Patent Brokerage.
Key Characteristics & Benefits
With priority dates from 1991, this extensive portfolio – including nineteen (19) U.S. granted patents – provides broad coverage for a range of medical techniques and associated instruments related to diagnostics and surgery. Importantly, the portfolio also includes forty expired assets that fall within a six year window from expiry, allowing a prospective purchaser to assert the entire portfolio's patent rights. The following represent a sampling of the assets in the portfolio:
See the patent portfolio summary of this medical device IP sales offering.
To learn more about the assets available for sale in this portfolio:
Contact Paul Greco of ICAP Patent Brokerage at (212) 815-6692 or via email at Paul.Greco@us.icap.com.
About ICAP Patent Brokerage
ICAP Patent Brokerage is a division of ICAP plc and the world's largest intellectual property brokerage and patent auction firm.
ICAP is a leading markets operator and provider of post trade risk mitigation and information services. The Group matches buyers and sellers in the wholesale markets in interest rates, credit, commodities, FX, emerging markets and equity derivatives through voice and electronic networks. Through its post trade risk mitigation and information services ICAP helps customers manage and mitigate risks in their portfolios. For more information, go to www.icap.com.
|SOURCE ICAP Patent Brokerage|
Copyright©2012 PR Newswire.
All rights reserved